FDA.reportPublic FDA data

Arbli 10 MG/mL Oral Suspension

RxCUI
2709046
RxNorm name
Arbli 10 MG/mL Oral Suspension
Display name
Arbli 10 MG/mL Oral Suspension
Full name
Arbli 10 MG/mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ARBLILOSARTAN POTASSIUMScienture LLCafd2d1ba-e7af-4e4e-8b7e-a9f72612fc972025-10-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2709046

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
afd2d1ba-e7af-4e4e-8b7e-a9f72612fc97Arbli 10 MG/mL Oral Suspension [PSN] · losartan potassium 10 MG/ML Oral Suspension [Arbli] [SBD] · Arbli 10 MG (equivalent to losartan 9.2 MG) per 1 mL Oral Suspension [SY] · losartan K+ 10 MG/ML Oral Suspension [Arbli] [SY] · losartan Pot 10 MG/ML Oral Suspension [Arbli] [SY]519These highlights do not include all the information needed to use ARBLI safely and effectively. See full prescribing information for ARBLI. ARBLI (losartan potassium) oral suspension, for oral use Initial U.S. Approval: 199520251003